HomeCompareVCLD vs MRK

VCLD vs MRK: Dividend Comparison 2026

VCLD yields 142857.14% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VCLD wins by $1.703105290929614e+28M in total portfolio value
10 years
VCLD
VCLD
● Live price
142857.14%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.703105290929614e+28M
Annual income
$17,007,633,297,048,937,000,000,000,000,000,000.00
Full VCLD calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — VCLD vs MRK

📍 VCLD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVCLDMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VCLD + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VCLD pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VCLD
Annual income on $10K today (after 15% tax)
$12,142,857.14/yr
After 10yr DRIP, annual income (after tax)
$14,456,488,302,491,595,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, VCLD beats the other by $14,456,488,302,491,595,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VCLD + MRK for your $10,000?

VCLD: 50%MRK: 50%
100% MRK50/50100% VCLD
Portfolio after 10yr
$8.51552645464807e+27M
Annual income
$8,503,816,648,524,468,000,000,000,000,000,000.00/yr
Blended yield
99.86%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

VCLD
No analyst data
Altman Z
-57.9
Piotroski
2/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VCLD buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVCLDMRK
Forward yield142857.14%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$1.703105290929614e+28M$57.7K
Annual income after 10y$17,007,633,297,048,937,000,000,000,000,000,000.00$10,113.78
Total dividends collected$1.70295189426983e+28M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: VCLD vs MRK ($10,000, DRIP)

YearVCLD PortfolioVCLD Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$14,296,414$14,285,714.29$11,213$373.04+$14.29MVCLD
2$19,102,632,658$19,087,335,494.95$12,667$512.06+$19102.62MVCLD
3$23,856,124,353,624$23,835,684,536,679.88$14,439$708.14+$23856124.34MVCLD
4$27,845,102,711,212,050$27,819,576,658,153,670.00$16,640$988.16+$27845102711.20MVCLD
5$30,376,787,884,694,190,000$30,346,993,624,793,194,000.00$19,432$1,394.07+$30376787884694.17MVCLD
6$30,972,831,647,170,750,000,000$30,940,328,484,134,132,000,000.00$23,057$1,992.90+$30972831647170752.00MVCLD
7$29,516,720,240,819,920,000,000,000$29,483,579,310,957,454,000,000,000.00$27,889$2,894.79+$29516720240819920896.00MVCLD
8$26,290,911,335,300,946,000,000,000,000$26,259,328,444,643,270,000,000,000,000.00$34,518$4,286.29+$2.6290911335300947e+22MVCLD
9$21,887,488,081,496,375,000,000,000,000,000$21,859,356,806,367,600,000,000,000,000,000.00$43,912$6,494.35+$2.1887488081496375e+25MVCLD
10$17,031,052,909,296,140,000,000,000,000,000,000$17,007,633,297,048,937,000,000,000,000,000,000.00$57,714$10,113.78+$1.703105290929614e+28MVCLD

VCLD vs MRK: Complete Analysis 2026

VCLDStock

Verecloud, Inc. operates as a technology company that provides cloud services in the United States. It develops and operates Cloudwrangler, a cloud service brokerage platform, which connects and integrates cloud service suppliers to small and medium size businesses (SMBs). The company distributes, manages, and bills for cloud services to SMBs. It serves customers directly; and through various distribution channels, including value added resellers, managed service providers, and communication service providers consisting of wireline and wireless telecommunications and cable companies. The company was formerly known as Network Cadence, Inc. and changed its name to Verecloud, Inc. in January 2010. Verecloud, Inc. was founded in 2006 and is headquartered in Englewood, Colorado.

Full VCLD Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this VCLD vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VCLD vs SCHDVCLD vs JEPIVCLD vs OVCLD vs KOVCLD vs MAINVCLD vs JNJVCLD vs ABBVVCLD vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.